Federation des caisses Desjardins du Quebec’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$69.7M Buy
2,480,449
+141,410
+6% +$3.76M 0.25% 62
2025
Q4
$58.2M Buy
2,339,039
+16,130
+0.7% +$407K 0.22% 75
2025
Q3
$59.2M Buy
2,322,909
+179,249
+8% +$4.42M 0.23% 73
2025
Q2
$52M Buy
2,143,660
+49,066
+2% +$1.14M 0.23% 76
2025
Q1
$53.1M Buy
2,094,594
+612,940
+41% +$16M 0.26% 71
2024
Q4
$39.3M Sell
1,481,654
-665,216
-31% -$18M 0.2% 88
2024
Q3
$62.1M Buy
2,146,870
+350,222
+19% +$10.2M 0.31% 54
2024
Q2
$50.3M Buy
1,796,648
+18,855
+1% +$519K 0.27% 65
2024
Q1
$49.4M Buy
1,777,793
+594,216
+50% +$16.5M 0.36% 58
2023
Q4
$34.1M Sell
1,183,577
-1,827
-0.2% -$55.2K 0.32% 64
2023
Q3
$39.3M Buy
1,185,404
+167,483
+16% +$5.92M 0.41% 57
2023
Q2
$37.3M Buy
1,017,921
+90,766
+10% +$3.53M 0.37% 58
2023
Q1
$37.8M Sell
927,155
-3,161
-0.3% -$137K 0.42% 55
2022
Q4
$47.7M Sell
930,316
-6,534
-0.7% -$313K 0.56% 42
2022
Q3
$41M Sell
936,850
-17,107
-2% -$831K 0.49% 50
2022
Q2
$50M Buy
953,957
+18,946
+2% +$965K 0.56% 45
2022
Q1
$48.4M Buy
935,011
+4,612
+0.5% +$239K 0.47% 49
2021
Q4
$54.9M Buy
930,399
+4,783
+0.5% +$237K 0.54% 47
2021
Q3
$39.8M Sell
925,616
-179,001
-16% -$7.93M 0.41% 53
2021
Q2
$43.3M Buy
1,104,617
+277,270
+34% +$10.8M 0.44% 52
2021
Q1
$30M Buy
827,347
+69,306
+9% +$2.46M 0.33% 62
2020
Q4
$27.9M Buy
758,041
+137,153
+22% +$5.03M 0.34% 64
2020
Q3
$21.6M Sell
620,888
-55,931
-8% -$1.96M 0.3% 73
2020
Q2
$21M Buy
676,819
+57,093
+9% +$1.94M 0.32% 72
2020
Q1
$19.2M Buy
619,726
+102,128
+20% +$3.48M 0.34% 65
2019
Q4
$19.2M Buy
517,598
+86,499
+20% +$3.08M 0.27% 66
2019
Q3
$14.7M Buy
431,099
+73,394
+21% +$2.67M 0.21% 82
2019
Q2
$14.7M Sell
357,705
-29,449
-8% -$1.17M 0.22% 86
2019
Q1
$15.6M Sell
387,154
-437,236
-53% -$17.5M 0.24% 79
2018
Q4
$34.1M Sell
824,390
-177,522
-18% -$7.37M 0.58% 37
2018
Q3
$41.9M Sell
1,001,912
-27,314
-3% -$1.05M 0.61% 34
2018
Q2
$35.4M Buy
1,029,226
+34,615
+3% +$1.18M 0.53% 38
2018
Q1
$33.5M Buy
994,611
+61,300
+7% +$2.11M 0.52% 38
2017
Q4
$32.1M Buy
933,311
+1,224
+0.1% +$41.7K 0.48% 42
2017
Q3
$31.6M Buy
932,087
+5,374
+0.6% +$173K 0.5% 37
2017
Q2
$29.5M Buy
926,713
+891,128
+2,504% +$28.1M 0.48% 38
2017
Q1
$1.15M Buy
+35,585
New +$1.12M 0.02% 522

Other funds holding PFE

Federation des caisses Desjardins du Quebec's PFE Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec increased its Pfizer (PFE) stake by 6% in Q1 2026, buying an estimated $3.76M and bringing the position to 2,480,449 shares worth $69.7M. The position accounts for 0.25% of the portfolio, ranked #62.

Federation des caisses Desjardins du Quebec first reported a position in PFE in Q1 2017 and has held it in 37 quarters since. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Federation des caisses Desjardins du Quebec held 2,480,449 shares of Pfizer worth $69.7M as of Q1 2026.
  • Federation des caisses Desjardins du Quebec bought 141,410 Pfizer shares in Q1 2026, an estimated $3.76M.
  • Pfizer made up 0.25% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #62 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Pfizer in Q1 2017 and has held it in 37 quarters since.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.